International Congress Amsterdam 2015

Saturday, 26.09.2015 Sunday, 27.09.2015 Monday, 28.09.2015 Tuesday, 29.09.2015 Wednesday, 30.09.2015		Sponsored symposia: Evening Symposium organised by Novartis Pharma AG: "IgE-mediated asthma: New revelations and future insights" Evening Symposium organised by Boehringer Ingelheim International GmbH: "The challenge of treating uncontrolled asthma on Step 3 and higher: Comparing options" Industry early morning symposium organised by Novartis Pharma AG: "Multidisciplinary approaches in the personalized care of the ALK + NSCLC patient"

Citations should be made in the following way: Authors. Title. Eur Respir J 2015; 46: Suppl. 59, abstract number.

PG2 Asthma and COPD

Postgraduate Course
Chairs: Ian Douglas Pavord (Oxford, United Kingdom), Marielle Pijnenburg (Rotterdam, Netherlands)
Aims: To discuss the problems associated with obstructive lung diseases on the basis of experience and the published literature.
Target audience: Paediatric and adult pulmonologists, epidemiologists, health professionals, public health physicians, and scientists interested in the aetiology and prevention of lung disease.

Educational Material

Handout PG2
Open

How to access educational materials from mobile devices

Download all media

The burden of obstructive lung diseases Anne Lindberg (Boden, Sweden)
Monitoring asthma – state-of-the-art physiological, imaging, and biomarker assessments Omar Usmani (London, United Kingdom)
Asthma exacerbations in children: the paediatrician’s view Bart Rottier (Groningen, Netherlands)
Asthma phenotypes Sally Wenzel (Pittsburgh, United States of America)
COPD phenotypes Christopher E. Brightling (Leicester, United Kingdom)
Exacerbations of obstructive lung disease Norbert Krug (Hannover, Germany)
The future: treating specific endotypes Peter J. Barnes (London, United Kingdom)